The National Institutes of Health (NIH, the US government's medical research agency) will award at least three major research grants focused on how ibogaine helps the brain rebuild neural connections in conditions like amblyopia (lazy eye), stroke, and traumatic brain injury. These studies are scientifically straightforward and don't involve addiction treatment, which makes them less politically controversial. This matters because government funding legitimizes the research and could open new medical uses.
Visual cortex plasticity findings are mechanistically tractable, use established animal models, and are politically uncontroversial compared to addiction or PTSD indications. NIH study sections respond to clean mechanistic novelty. However, grant cycles are 12-18 months from submission to funding decision, making the 18-month window tight. The prediction is made specific and falsifiable by requiring documented funded R01s (searchable in NIH Reporter), not merely applications. Confidence is tempered by the lag between published findings and grant funding cycles.